PSI’s Feasibility Services form the core of our medical affairs department. In an industry where as many as 94% of clinical trials fall behind schedule, PSI consistently delivers refreshing accuracy and predictability. One of the key factors is our feasibility unit that requires a dedicated and determined investment of time and MD resources.
A dedicated full-time feasibility group gives every project a thorough and customized assessment. Our feasibility group is staffed by experienced physicians from various therapeutic backgrounds, laboratory experts, imaging specialists, logisticians, and regulatory advisors. They painstakingly assess each and every aspect of the protocol to determine its potential impact on study enrollment.
We apply our years of experience and relationships with investigators to determine the best sites and countries for each protocol. Such issues as patient availability, competing studies, standards of care and regulatory hurdles are all weighed before making recommendations for the geomix and investigators.
These dedicated professionals determine clinical trial study feasibility for each criterion:
- Medical feasibility
- Clinical feasibility
- Logistical feasibility
- Regulatory feasibility
When assessing the feasibility of a clinical trial, we cover all the bases so our predictions are accurate and predictable. We then engage our Global Project Management and Clinical Operations staff who will leverage their education and experience to support and manage the site relationships as we meet these enrollment goals.
Please contact PSI to understand how the accuracy of our clinical trial feasibility services could help you to achieve your study goals.